institutes health u.k. medical research council striking deals abandoned drugs pipelines release information publicly nih national center advancing translational sciences provides legal framework lets companies protect interests sharing drug data initiatives create similar databases approved failed drugs way information funneled centralized resource existing data approved drugs combined explosion genetic knowledge related underlying disease mechanisms revelation researchers employ latest tools bioinformatics data science machine learning uncover common molecular themes diseases potential drugs ultimately key access pharmaceutical companies reluctant reveal jeopardize intellectual property academics hesitate share competing laboratories remedy fda similar entities develop incentives sharing data creating legal safeguards privacy commercial interests